Skip to main content

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Resources

Cancer Data Access System (CDAS)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	LeeVan, Elyse, M.D., M.P.H. elyse.leevan@nih.gov 240-276-7314	5E110	Program Officer \| Early Detection
	McCarty, Larae larae.mccarty@nih.gov 240-276-5777	5E322	Program Specialist \| Community Oncology and Prevention Trials Early Detection
	Miller, Eric, Ph.D. eric.miller2@nih.gov 240-276-5336	5E212	Program Officer \| Early Detection
	Ong, Mary Jane maryjane.ong@nih.gov 240-858-3296	5E120	Nurse Consultant \| Early Detection
	Pinsky, Paul, Ph.D. paul.pinsky@nih.gov 240-276-7014	5E108	Chief \| Early Detection
	Saxena, Neeraj, Ph.D. neeraj.saxena@nih.gov 240-276-6302	5E218	Program Officer \| Early Detection
	Zhu, Claire, Ph.D. claire.zhu@nih.gov 240-276-7013	5E106	Program Officer \| Early Detection

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Iyer, Prasad G.	Mayo Clinic Arizona United States	Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma	2R01CA241164-07	Matthew Young, Ph.D.
Jacob, Jennifer B	Henry Ford Health + Michigan State University Health Sciences United States	Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice	5R01CA278818-03
James, Aimee S	Washington University United States	Administrative Supplement to Building equity in cancer screening through research: The Siteman Catchment CSRN Hub	3UG1CA286946-02S1	Elyse LeeVan, M.D., M.P.H.
Jang, Mi-Hyeon	Rutgers Biomedical And Health Sciences United States	Identification of novel biomarkers and therapeutic strategies in chemobrain.	5R01CA293210-02	John Clifford, Ph.D.
Jaslowski, Anthony J	St. Vincent Hospital United States	Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium	3UG1CA239769-06S1	Vanessa A. White, M.P.H.
Ji, Hanlee P	Stanford University United States	Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification	5P01CA265772-03	Asad Umar, D.V.M., Ph.D.
Ji, Hanlee P	Stanford University United States	Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection	5U01CA282212-02	Claire Zhu, Ph.D.
Jiang, Qing	Purdue University United States	Anti-cancer effects of tocotrienols and a carboxychromanol in an innovative colon cancer model	5R03CA283236-02	Amit Kumar, Ph.D.
Jiang, Feng	Biotarget Dx Llc United States	Plasma microRNA biomarkers for lung cancer diagnosis	7UH3CA251139-05	Guillermo Marquez, Ph.D.
Jim, Heather S.L.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer	5R34CA289918-02	Brennan Streck, Ph.D., RN, M.P.H.
Jim, Heather S.L.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue	5R01CA214647-05	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Jobin, Christian	University Of Florida United States	Interaction between dietary taurine and microbiota sulfur metabolism in the development of colorectal cancer	1R01CA296643-01	Young Kim, Ph.D.
John, Esther M.	Stanford University United States	Stress, inflammation, and health-related quality of life of long-term breast cancer survivors	1R21CA290430-01	Brennan Streck, Ph.D., RN, M.P.H.
Johnson, Constance Margaret	University Of Texas Hlth Sci Ctr Houston United States	Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy	3R01CA245054-05S1	Rachel Altshuler, Ph.D.
Johnson, Jeremy James	University Of Illinois At Chicago United States	Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer	5R37CA227101-07	Amit Kumar, Ph.D.